Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma

Takahashi, Yu; Nagino, Masato; Nishio, Hisahide; Ebata, Tomoki; Igami, Tsuyoshi; Nimura, Yuji

doi:10.1002/bjs.7228

Cited by 156 publications

(132 citation statements)

References 31 publications

(57 reference statements)

Supporting

Mentioning

125

Contrasting

Order By: Relevance

“…Meta-analyses comparing EBD with PTBD in patients with malignant biliary obstruction have reported that PTBD has a higher success rate, with no significant difference in complications as compared with EBD [6]. However, because PTBD carries the risk of tumor cell dissemination [7], it is unsuitable for surgical patients and is difficult to perform in patients with ascites or Chilaiditi's syndrome. On the other hand, although EBD has been reported to have a low success rate, bile flow is physiological if EBD is successful, thereby contributing to maintaining a better quality of life than an external fistula.…”

Section: Introductionmentioning

confidence: 94%

A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 94%

A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy

et al. 2016

View full text Add to dashboard Cite

show abstract

“…However, it should be noted that catheter tract recurrence occurred in 5-6% of cases within patients who received PTBD [66,67]. PTBD only for cytological or histological analysis is not recommended.…”

Section: Cq2: Is a Cholecystectomy Necessary For Polypoid Lesions Of mentioning

confidence: 99%

Clinical practice guidelines for the management of biliary tract cancers 2015: the 2^nd English edition

Miyazaki

Yoshitomi

Miyakawa³

et al. 2015

J Hepato Biliary Pancreat

236

165

View full text Add to dashboard Cite

Background The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract and ampullary carcinomas in 2008. Novel treatment modalities and handling of clinical issues have been proposed after the publication. New approaches for editing clinical guidelines, such as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, also have been introduced for better and clearer grading of recommendations. Methods Clinical questions (CQs) were proposed in seven topics. Recommendation, grade of recommendation and statement for each CQ were discussed and finalized by evidencebased approach. Recommendation was graded to grade 1 (strong) and 2 (weak) according to the concept of GRADE system. Results The 29 CQs covered seven topics: (1) prophylactic treatment, (2) diagnosis, (3) biliary drainage, (4) surgical treatment, (5) chemotherapy, (6) radiation therapy, and (7) pathology. In 27 CQs, 19 recommendations were rated strong and 11 recommendations weak. Each CQ included the statement of how the recommendation was graded. Conclusions This guideline provides recommendation for important clinical aspects based on evidence. Future collaboration with cancer registry will be a key for assessment of the guidelines and establishment of new evidence. Free full-text articles and a mobile application of this guideline are available via

show abstract

“…39,40 Currently, there are no significant differences in sensitivity and complications between cytology/biopsy with ERCP or PTC, but more attention should be paid to the fact that catheter tract implantation metastasis is not a rare complication following PTBD in ECC. 41,42 The study of Kim et al 43 indicated that PTC in combination with IDUS was highly accurate for assessing Bismuth type in patients with hilar CCA, which may help in the identification of an optimal surgical plan for the treatment of hilar CCA, especially in Bismuth type III and IV. IDUS images also have important clinical significance in the differentiation of malignant and benign lesions.…”

Section: Diagnosismentioning

confidence: 99%

A review of the clinical diagnosis and therapy of cholangiocarcinoma

2013

View full text Add to dashboard Cite

Cholangiocarcinoma (CCA) is the second most common primary hepatic malignancy worldwide. The incidence of intrahepatic CCA is increasing, whereas that of extrahepatic CCA is decreasing. This review looks at the new advances that have been made in the management of CCA, based on a PubMed and Science Citation Index search of results from randomized controlled trials, reviews, and cohort, prospective and retrospective studies. Aggressive interventional approaches and new histopathological techniques have been developed to make a histological diagnosis in patients with high risk factors or suspected CCA. Resectability of the tumour can now be assessed using multiple radiological imaging studies; the main prognostic factor after surgery is a histologically negative resection margin. Biliary drainage and/or portal vein embolization may be performed before extended radical resection, or liver transplantation may be undertaken in combination with neoadjuvant chemotherapy or chemoradiotherapy. Though many advances have been made in the management of CCA, the standard modality of treatment has not yet been established. This review focuses on the clinical options for different stages of CCA.

show abstract

Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma

Abstract: PTBD catheter tract recurrence is not unusual. The prognosis for these patients is generally poor, even after resection. To prevent this troublesome complication, endoscopic biliary drainage is first recommended when drainage is indicated.

Cited by 156 publications

References 31 publications

A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy

A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy

Clinical practice guidelines for the management of biliary tract cancers 2015: the 2^nd English edition

A review of the clinical diagnosis and therapy of cholangiocarcinoma

Contact Info

Product

Resources

About

Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma

Abstract: PTBD catheter tract recurrence is not unusual. The prognosis for these patients is generally poor, even after resection. To prevent this troublesome complication, endoscopic biliary drainage is first recommended when drainage is indicated.

Cited by 156 publications

References 31 publications

A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy

A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy

Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition

A review of the clinical diagnosis and therapy of cholangiocarcinoma

Contact Info

Product

Resources

About

Clinical practice guidelines for the management of biliary tract cancers 2015: the 2^nd English edition